Sarangan, Rayna S.
HRN: 24-01-34 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
MUPIROCIN 2%, 15G (TUBE)
11/04/2023
11/11/2023
TOPICAL
2%
BID
Infected Wound Lateral Neck
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes